The US Food and Drug Administration (FDA) has allowed marketing of the DEKA Arm System - the first prosthetic arm that can perform multiple, simultaneous powered movements controlled by electrical signals from electromyogram (EMG) electrodes.
EMG electrodes detect electrical activity caused by the contraction of muscles close to where the prosthesis is attached, FDA said.
The electrodes send the electrical signals to a computer processor in the prosthesis that translates them to a specific movement or movements.
In addition to the EMG electrodes, the system contains a combination of mechanisms including switches, movement sensors, and force sensors that cause the prosthesis to move.
Also Read
"This innovative prosthesis provides a new option for people with certain kinds of arm amputations," said Christy Foreman, director of the Office of Device Evaluation at the FDA's Center for Devices and Radiological Health.
"The DEKA Arm System may allow some people to perform more complex tasks than they can with current prostheses in a way that more closely resembles the natural motion of the arm," said Foreman.
The study found that approximately 90 per cent of participants were able to perform activities with the system that they were not able to perform with their current prosthesis, such as using keys and locks, preparing food, feeding oneself, using zippers, and brushing and combing hair.
The DEKA Arm System can be configured for people with limb loss occurring at the shoulder joint, mid-upper arm, or mid-lower arm. It cannot be configured for limb loss at the elbow or wrist joint.